| 序 | 課程題目 | 講師姓名 | 上課日期 | 起訖時間 | 課程類型 | 課程性質 | 學員 積分 |
|---|---|---|---|---|---|---|---|
| 1 | 【S1-1】：Epithelial-mesenchymal plasticity in cancer progression: mechanisms and clinical significance | 楊慕華 | 109.11.20 | 08:30~09:00 | 專業課程 | 0.6 | |
| 2 | 【S1-2】：Precision Medicine in Oncology Practice: Taiwan vs Neighborhood Asian Counties | 陳立宗 | 109.11.20 | 09:00~09:30 | 專業課程 | 0.6 | |
| 3 | 【S1-3】：H. pylori eradication to improve the control of gastric cancer and precancerous lesions | 許博翔 | 109.11.20 | 09:30~10:00 | 專業課程 | 0.6 | |
| 4 | 【S1-4】：Arginine, mitochrondria and Cancer Metabolism | 龔行健 | 109.11.20 | 10:30~11:00 | 專業課程 | 0.6 | |
| 5 | 【S1-5】：Hepatitis C virus related Hepatocellular Carcinoma before and after viral eradication | 余明隆 | 109.11.20 | 11:00~11:30 | 專業課程 | 0.6 | |
| 6 | 【S1-6】： Androgen regulated miRNA-887 downregulates ER-cation channel protein TMEM38B to activate PKC and promote breast cancer cell metastasis | 王陸海 | 109.11.20 | 11:30~12:00 | 專業課程 | 0.6 | |
| 7 | 【S1-7】：Tracking HBV-related Liver Carcinogenesis by Monitoring Circulating virus-host Chimera DNA | 陳培哲 | 109.11.20 | 13:00~13:30 | 專業課程 | 0.6 | |
| 8 | 【S1-8】：Dissecting the Conformation of Glycans and Their Interactions with Proteins for Tumor Microenvironment and Pregnancy | 游正博 | 109.11.20 | 13:30~14:00 | 專業課程 | 0.6 | |
| 9 | 【S1-9】：Breaking the Brake for Early Metastasis | 蔡少正 | 109.11.20 | 14:00~14:30 | 專業課程 | 0.6 | |
| 10 | 【S1-10】：Immunotherapy targeting the protumor secretion pathways for cancer treatment | 王憶卿 | 109.11.20 | 14:30~15:00 | 專業課程 | 0.6 | |
| 11 | 【S1-11】：Visfatin Mediates Malignant Behaviors through Adipose-Derived Stem Cells Intermediary in Breast Cancer | 袁行修 | 109.11.20 | 15:30~16:00 | 專業課程 | 0.6 | |
| 12 | 【S1-12】：Role of Selective Autophagy Receptors in Cancers and Nanodrug Delivery | 趙瑞益 | 109.11.20 | 16:00~16:30 | 專業課程 | 0.6 | |
| 13 | 【S1-13】：Amplification-driven BCL6-suppressed cytostasis is mediated by transrepression of FOXO3 and post-translational modifications of FOXO3 in urinary bladder urothelial | 薛佑玲 | 109.11.20 | 16:30~17:00 | 專業課程 | 0.6 | |
| 14 | 【S2-1】The implementation and challenge of the Long-Term Care 2.0 program in Taiwan | 薛瑞元 | 109.11.20 | 08:30~09:30 | 專業品質 | 1.2 | |
| 15 | 【S2-2】：The Opportunities and Creation of Home-based Care Industry | 林依瑩 | 109.11.20 | 09:30~10:30 | 專業品質 | 1.2 | |
| 16 | 【S2-3】：The Development of Community-based Long-Term Care Management based on the experience of Chiayi and its Future Development | 黎世宏 | 109.11.20 | 10:50~11:50 | 專業品質 | 1.2 | |
| 17 | 【S2-4】：視訊場State-of-the-art Telemedicine Promoted by Asahikawa Medical University | 吉田晃敏 | 109.11.20 | 13:30~14:30 | 專業課程 | 1.2 | |
| 18 | 【S2-5】：視訊場The emergence of welfare based social challenges under the long-term-care | 尻無浜博幸 | 109.11.20 | 14:45~15:45 | 專業品質 | 1.2 | |
| 19 | 【S3-1】：視訊Sequence of chemotherapy agent choice in metastatic breast cancer | 大野真司 | 109.11.21 | 09:10~09:40 | 專業課程 | 0.6 | |
| 20 | 【S3-2】：視訊New Treatment Landscape for HER2 positive Early Breast Cancer | 石川孝 | 109.11.21 | 09:40~10:10 | 專業品質 | 0.6 | |
| 21 | 【S3-3】：KATHERINE Trial: Transformational Breakingthrough in HER2-Positive Early Breast Cancer | 黃俊升 | 109.11.21 | 10:10~10:40 | 專業課程 | 0.6 | |
| 22 | 【S3-4】：Bringing Biosimilars to Life: clinical experience of Kanjinti | 曾彥敦 | 109.11.21 | 11:00~11:30 | 專業課程 | 0.6 | |
| 23 | 【S3-5】：視訊Product Reflects Process: Dissecting Complex Manufacturing of Biosimilars | 劉玲君 | 109.11.21 | 11:30~12:00 | 專業課程 | 0.6 | |
| 24 | 【S3-6】：The complexity and considerations of biologics from clinical perspective | 莊捷翰 | 109.11.21 | 12:00~12:30 | 專業課程 | 0.6 | |
| 25 | 【S3-7】：Hormone Receptor-Positive Advanced Breast Cancer: Toward a Chemotherapy-Free Era | 饒坤銘 | 109.11.21 | 13:30~14:00 | 專業課程 | 0.6 | |
| 26 | 【S3-8】：Optimization and patient segmentation of CDK4/6 treatment efficacy in 1L mBC | 郭玟伶 | 109.11.21 | 14:00~14:30 | 專業課程 | 0.6 | |
| 27 | 【S3-9】：Optimizing endocrine treatment in HR+HER2- metastatic breast cancer | 趙大中 | 109.11.21 | 14:30~15:00 | 專業課程 | 0.6 | |
| 28 | 【S3-10】：Overall survival matters in pre-menopausal metastasis breast cancer | 劉建廷 | 109.11.21 | 15:00~15:30 | 專業課程 | 0.6 | |
| 29 | 【S3-11】：Selecting Treatment for Patients with Germline BRCA-mutated Locally Advanced/Metastatic Breast Cancer | 鍾為邦 | 109.11.21 | 15:50~16:20 | 專業課程 | 0.6 | |
| 30 | 【S3-12】：Genomic landscape of breast cancer in Taiwan: with emphasize on the translation into therapeutics | 李健逢 | 109.11.21 | 16:20~16:50 | 專業品質 | 0.6 | |
| 31 | 【S3-13】：Cell therapy in Breast cancer: Current evidence and indication | 蕭君平 | 109.11.21 | 16:50~17:20 | 專業課程 | 0.6 | |
| 32 | 【S3-14】：視訊Artificial intelligence (AI) application in ultrasound diagnosis of breast cancer | 林田哲 | 109.11.22 | 09:00~09:30 | 專業課程 | 0.6 | |
| 33 | 【S3-15】：Clinical implication of eribulin in related to tumor immune microenvironment . | 饒坤銘 | 109.11.22 | 09:30~10:00 | 專業課程 | 0.6 | |
| 34 | 【S3-16】：Novel therapeutic strategies for patients with triple-negative breast cancer | 劉良智 | 109.11.22 | 10:00~10:30 | 專業課程 | 0.6 | |
| 35 | 【S3-17】：Emerging evidence of immunotherapy in TNBC | 劉建廷 | 109.11.22 | 10:50~11:20 | 專業課程 | 0.6 | |
| 36 | 【S3-18】：The Perspectives of Neoadjuvant Therapy in Breast Cancer and Real World Data in Single Institute | 洪志強 | 109.11.22 | 11:20~11:50 | 專業課程 | 0.6 | |
| 37 | 【S4-1】：HER2 Regimen for Metastasis Gastric Cancer in ToGA trial and RWD experience sharing | 陳明晃 | 109.11.21 | 10:30~11:00 | 專業課程 | 0.6 | |
| 38 | 【S4-2】：Evolving Treatment Opitons for Partients with Refractory mCRC : TKI to precision medicine | 林哲弘 | 109.11.21 | 11:00~11:30 | 專業課程 | 0.6 | |
| 39 | 【S4-3】：視訊To Test or Not to Test:The New Era of Biomarker Based mCRC Treatment | Yoshiaki Nakamura | 109.11.21 | 11:30~12:15 | 專業課程 | 0.9 | |
| 40 | 【S4-4】：Therapeutic strategies of bevacizumab with different chemo-partners in first and second line to improve the continuum of care in mCRC | 黃聖捷 | 109.11.21 | 13:15~13:45 | 專業課程 | 0.6 | |
| 41 | 【S4-5】：視訊What is the role of anti-angiogenic agents in the treatment of colorectal cancer? | Kei Muro | 109.11.21 | 13:45~14:30 | 專業課程 | 0.9 | |
| 42 | 【S4-6】：Systemic treatment strategies to optimized cytoreduction and disease control in RAS WT mCRC | 謝孟哲 | 109.11.21 | 14:30~15:15 | 專業課程 | 0.9 | |
| 43 | 【S4-7】：視訊Where we stand with IO in mCRC: challenges and potentials | Tan Bee Huat Iain | 109.11.21 | 15:35~16:20 | 專業課程 | 0.9 | |
| 44 | 【S4-8】：視訊Robotic pelvic node dissection: | James Ngu | 109.11.21 | 16:20~17:05 | 專業課程 | 0.9 | |
| 45 | 【S4-9】：Comprehensive Genomic Profiling to Maximize Options in Metastatic Colorectal Cancer | 官鋒澤 | 109.11.21 | 17:05~17:35 | 專業課程 | 0.6 |